OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
July 05, 2017
ADV7103 is being evaluated in a Phase III trial in Europe in children and adults with distal renal tubulopathy acidosis. Results from the study are expected in the coming months.
July 03, 2017
The Spanish CDMO has installed a new automatic capsule filling machine at its EU GMP-approved plant in Pamplona, Spain
July 02, 2017
Industry experts discuss the single-use revolution and changes to upstream and downstream processing equipment.
Oral solid-dosage and parenteral drug manufacturing equipment and systems have made great strides in safety and efficiency.
Anil Kane, executive director, Global Head of Technical & Scientific Affairs at Patheon, shared his perspective of changes to solid-dosage pharmaceutical manufacturing.
Tablet coating from DISONA can handle batch sizes up to 3 kg.
The BIOSTAT STR single-use bioreactor family from Sartorius Stedim Biotech is based on a conventional stirred-tank design.
Poly(lactide-glycolide) has been used for drug-delivery applications because of its beneficial physicochemical properties, long safety record, and reliable commercial supply.
Materials and equipment innovations have advanced tablet coating from sugar to copolymers and simplified pharma production.
Real-time alternatives to dissolution testing are required for continuous manufacturing to reach mainstream use.